Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | sema domain-containing protein | 0.0022 | 0.2348 | 0.2348 |
Loa Loa (eye worm) | voltage and ligand gated potassium channel | 0.0037 | 0.5312 | 0.5312 |
Echinococcus multilocularis | hypothetical protein | 0.0022 | 0.2348 | 0.2348 |
Loa Loa (eye worm) | hypothetical protein | 0.0022 | 0.2348 | 0.2348 |
Loa Loa (eye worm) | hypothetical protein | 0.0022 | 0.2348 | 0.2348 |
Brugia malayi | Voltage-gated potassium channel, HERG (KCNH2)-related. C. elegans unc-103 ortholog | 0.0037 | 0.5312 | 0.5312 |
Brugia malayi | Sema domain containing protein | 0.0022 | 0.2348 | 0.2348 |
Brugia malayi | Sema domain containing protein | 0.0022 | 0.2348 | 0.2348 |
Loa Loa (eye worm) | hypothetical protein | 0.0052 | 0.8169 | 0.8169 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0011 | 0.0239 | 0.0292 |
Trichomonas vaginalis | voltage and ligand gated potassium channel, putative | 0.0035 | 0.4842 | 1 |
Onchocerca volvulus | 0.0052 | 0.8169 | 1 | |
Loa Loa (eye worm) | hypothetical protein | 0.003 | 0.3991 | 0.3991 |
Brugia malayi | hypothetical protein | 0.0022 | 0.2348 | 0.2348 |
Echinococcus multilocularis | potassium voltage gated channel subfamily H | 0.0011 | 0.0239 | 0.0239 |
Echinococcus multilocularis | voltage gated potassium channel | 0.0011 | 0.0239 | 0.0239 |
Schistosoma mansoni | plexin | 0.0052 | 0.8169 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0011 | 0.0239 | 0.0239 |
Schistosoma mansoni | hypothetical protein | 0.0022 | 0.2348 | 0.2874 |
Entamoeba histolytica | tyrosin kinase, putative | 0.0012 | 0.0489 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.4369 | 0.4369 |
Schistosoma mansoni | hypothetical protein | 0.0022 | 0.2348 | 0.2874 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0011 | 0.0239 | 0.0292 |
Loa Loa (eye worm) | hypothetical protein | 0.0022 | 0.2348 | 0.2348 |
Echinococcus granulosus | plexin a4 | 0.0062 | 1 | 1 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0012 | 0.0489 | 1 |
Brugia malayi | hypothetical protein | 0.0022 | 0.2348 | 0.2348 |
Schistosoma mansoni | hypothetical protein | 0.003 | 0.3991 | 0.4885 |
Echinococcus granulosus | potassium voltage gated channel subfamily H | 0.0011 | 0.0239 | 0.0239 |
Loa Loa (eye worm) | hypothetical protein | 0.0022 | 0.2348 | 0.2348 |
Schistosoma mansoni | semaphorin 5-related | 0.0022 | 0.2348 | 0.2874 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0041 | 0.5968 | 0.7306 |
Brugia malayi | Plexin repeat family protein | 0.0052 | 0.8169 | 0.8169 |
Loa Loa (eye worm) | plexin A | 0.0062 | 1 | 1 |
Loa Loa (eye worm) | sema domain-containing protein | 0.0022 | 0.2348 | 0.2348 |
Echinococcus granulosus | voltage gated potassium channel | 0.0011 | 0.0239 | 0.0239 |
Trichomonas vaginalis | voltage and ligand gated potassium channel, putative | 0.0035 | 0.4842 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0022 | 0.2348 | 0.2348 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0041 | 0.5968 | 0.7306 |
Loa Loa (eye worm) | hypothetical protein | 0.0022 | 0.2348 | 0.2348 |
Echinococcus multilocularis | semaphorin 5B | 0.0022 | 0.2348 | 0.2348 |
Echinococcus granulosus | semaphorin 1A | 0.0022 | 0.2348 | 0.2348 |
Schistosoma mansoni | plexin | 0.003 | 0.3991 | 0.4885 |
Echinococcus multilocularis | plexin a4 | 0.0062 | 1 | 1 |
Echinococcus multilocularis | potassium voltage gated channel subfamily H | 0.0037 | 0.5312 | 0.5312 |
Echinococcus granulosus | potassium voltage gated channel subfamily H | 0.0037 | 0.5312 | 0.5312 |
Brugia malayi | Voltage-gated potassium channel, EAG (KCNH1)-related. C. elegans egl-2 ortholog | 0.0011 | 0.0239 | 0.0239 |
Echinococcus granulosus | semaphorin 5B | 0.0022 | 0.2348 | 0.2348 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.